EKF Diagnostics (LON:EKF – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported GBX 0.54 earnings per share for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 4.86% and a return on equity of 3.58%.
EKF Diagnostics Trading Up 4.0%
LON EKF traded up GBX 1 during trading hours on Thursday, hitting GBX 26. The company’s stock had a trading volume of 769 shares, compared to its average volume of 324,610. The stock has a fifty day moving average of GBX 25.43 and a 200 day moving average of GBX 25.51. EKF Diagnostics has a twelve month low of GBX 22 and a twelve month high of GBX 31.70. The firm has a market capitalization of £111.32 million, a P/E ratio of 55.32 and a beta of 0.50. The company has a quick ratio of 1.77, a current ratio of 4.72 and a debt-to-equity ratio of 2.09.
EKF Diagnostics Company Profile
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
Featured Articles
- Five stocks we like better than EKF Diagnostics
- CoreWeave’s Vera Rubin Lead Comes Down to Speed, Power, and Scale
- Micron’s New 512GB Memory Module Deepens Its AI Infrastructure Advantage
- Banc of California Bets on Short-Term Pain
- Enterprise AI to Boost Broadcom’s Software Business? What Industry Data Shows
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
